Alpha Teknova (TKNO) Income from Continuing Operations (2020 - 2026)
Alpha Teknova (TKNO) reported Income from Continuing Operations of 4555000.0 for Q1 2026, up 1.94% year-over-year from 4468421.33 in Q1 2025, and up 3.23% quarter-over-quarter from 4707000.0 in Q4 2025.
Alpha Teknova (TKNO) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Income from Continuing Operations data on file, last reported at 4555000.0 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 4555000.0, up 1.94% year-over-year; the trailing twelve-month figure through Mar 2026 was 17118000.0 (up 26.67% YoY), and the FY2025 annual result was 17208000.0, up 35.66% from the prior year.
- Income from Continuing Operations rose to 4555000.0 in Q1 2026 per TKNO's latest filing, from 4707000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 3570000.0 in Q2 2025 and troughed at 22448000.0 in Q3 2022.
- A 5-year average of 7808647.06 and a median of 6198000.0 in 2022 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2022 and 2023: Income from Continuing Operations tumbled 739.24% in 2022, then soared 54.77% in 2023.
- A 5-year view of Income from Continuing Operations shows it stood at 13266000.0 in 2022, then gained by 19.67% to 10656000.0 in 2023, then soared by 45.86% to 5769000.0 in 2024, then grew by 18.41% to 4707000.0 in 2025, then rose by 3.23% to 4555000.0 in 2026.
- Business Quant data shows TKNO's Income from Continuing Operations at 4555000.0 in Q1 2026, 4707000.0 in Q4 2025, and 4286000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 21.05 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -92.12 Mn |
| 10 | Alpha Teknova | 249.27 Mn | 231.49 Mn | 3.78 Mn | -4.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.56 Mn |
| Dec 31, 2025 | -4.71 Mn |
| Sep 30, 2025 | -4.29 Mn |
| Jun 30, 2025 | -3.57 Mn |
| Mar 31, 2025 | -4.65 Mn |
| Dec 31, 2024 | -5.77 Mn |
| Sep 30, 2024 | -7.57 Mn |
| Jun 30, 2024 | -5.36 Mn |
| Mar 31, 2024 | -8.10 Mn |
| Dec 31, 2023 | -10.66 Mn |
| Sep 30, 2023 | -10.15 Mn |
| Jun 30, 2023 | -7.15 Mn |
| Mar 31, 2023 | -8.82 Mn |
| Dec 31, 2022 | -13.27 Mn |
| Sep 30, 2022 | -22.45 Mn |
| Jun 30, 2022 | -6.20 Mn |
| Mar 31, 2022 | -5.50 Mn |
| Dec 31, 2021 | -6.44 Mn |
| Sep 30, 2021 | -3.24 Mn |
| Jun 30, 2021 | -2.23 Mn |